Corpus Intelligence IC Memo — PINNACLE HOSPITAL 2026-04-26 07:45 UTC
IC Memo — PINNACLE HOSPITAL
Investment Committee Memorandum | IN | 18 beds | Grade C | EBITDA uplift $4.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PINNACLE HOSPITAL

CCN 150166 | LAKE, IN | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PINNACLE HOSPITAL is a 18-bed suburban community hospital in LAKE, IN with $57.3M in net patient revenue and a 1.9% operating margin. The hospital serves a payer mix of 40.9% Medicare, 0.6% Medicaid, and 58.5% commercial.

Thesis: Turnaround. Our ML models identify $4.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.9% to 9.2% (+736bps).

Net Revenue HCRIS$57.3M
Current EBITDA COMPUTED$1.1M
Operating Margin COMPUTED1.9%
Occupancy HCRIS26.7%
Revenue / Bed COMPUTED$3.2M
Net-to-Gross HCRIS12.6%
Distress Probability ML48.1%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
61
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 1.9% places it above the state median. Among 61 size-comparable peers (9-36 beds), the median margin is -5.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 61 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PINNACLE HOSPITAL (Target)IN18$57.3M1.9%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
CAMERON MEMORIAL COMMUNITY HOSIN25$95.1M7.4%
THE OTIS R. BOWEN CENTERIN20$92.4M-11.2%
WHITLEY MEMORIAL HOSPITALIN30$87.8M1.1%
ADAMS MEMORIAL HOSPITALIN25$76.5M0.1%
DECATUR CO. MEMORIAL HOSPITALIN25$75.7M-19.8%
COMMUNITY HOSPITAL OF NOBLE CTIN31$71.4M1.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$697K+122bp9mo
Clean Claim Rate88.0%96.0%$37K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$697K
Clean Claim Rate
$37K
Total EBITDA Uplift$4.2M
Current EBITDA$1.1M
+ RCM Uplift+$4.2M
Pro Forma EBITDA$5.3M
Current Margin1.9%
Pro Forma Margin9.2%
WC Released (1x)$2.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.6M$49.2M30.15x97.6%
Base (11x exit)10.0x11.0x$1.6M$54.6M33.49x101.8%
Bull Case9.0x11.0x$1.5M$69.1M47.05x116.0%
Bull (12x exit)9.0x12.0x$1.5M$75.8M51.62x120.1%
Bear Case11.0x10.0x$1.8M$27.6M15.36x72.7%
Bear (11x exit)11.0x11.0x$1.8M$30.9M17.22x76.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 26.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 61 hospitals with 9-36 beds
  • Same-state prioritization (n=62)
  • Comp margins: P25=-19.8% / P50=-5.8% / P75=3.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.